Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
July 2024
in “
Journal of Market Access & Health Policy
”
Studysummary This paper discusses the introduction and advantages of an Insurance-Based Billing Model for scalp cooling devices in the USA, which can enhance access to this treatment for reducing chemotherapy-induced alopecia, particularly benefiting underserved and disadvantaged populations.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer